Plasma levels of brain-derived neurotrophic factor and interleukin-6 in patients with dysthymic disorder: Comparison with age- and sex-matched major depressed patients and healthy controls

Human Psychopharmacology

Volumn 25, Issue 7-8, 2010, Pages 566-569

  Yoshimura, Reiji ^a   Umene Nakano, Wakako ^a,b   Hoshuyama, Tsutomu ^a   Ikenouchi Sugita, Atsuko ^a   Hori, Hikaru ^a   Katsuki, Asuka ^a   Hayashi, Kenji ^a   Atake, Kiyokazu ^a   Nakamura, Jun ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b Ushibuka City Hospital   (Japan)

Author keywords

brain derived neurotrophic factor; depression; dysthymic disorder; interleukin 6; plasma

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 6;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DYSTHYMIA; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; DYSTHYMIC DISORDER; FEMALE; HUMANS; INTERLEUKIN-6; MALE; PSYCHIATRIC STATUS RATING SCALES;

EID: 79951743859     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1155     Document Type: Article

References (22)

1. Anisman H, Ravindran A, Griffiths J, Merali Z,. 1999. Interleukin-1β production in dysthymia before and after pharmacotherapy. Biol Psychiatry 46: 1649-1655.
2. Aydemir O, Deveci A, Taskin OE, Taneli F, Esen-Danaci A,. 2007. Serum brain-derived neurotrophic factor level in dysthymia: a comparative study with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 31: 1023-1026. (Pubitemid 46810091)
3. Berk M, Wadee AA, Kuschker RH, O Neil-Kerr A,. 1997. Acute phase proteins in major depression. J Psychosom Res 43: 529-534. (Pubitemid 27487544)
4. Brunori AR, Lopes M, Fregni A,. 2008. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol 11: 1169-1180.
5. Duman RS, Malberg J, Nakagawa SD, Sa C,. 2000. Neuronal plasticity and survival in mood disorders. Biol Psychiatry 48: 732-739.
6. Figurov A, Pozzo-Miller LD, Olafsson P, Wang T, Lu B,. 2006. Regulation of synaptic response to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 381: 706-709.
7. Frommberger UH, Bauer J, Hasellbauer P, Franklin Riemann D, Berger M,. 1997. Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci 247: 228-233. (Pubitemid 27399827)
8. Kline DN, Schazberg AF, McCullogh JP, Keller MB, Dowling F, Goodman D, et al,. 1999. Early- versus late-onset dysthymic disorder: comparison in out-patients with superimposed major depressive episodes. J Affect Disord 52: 187-196. (Pubitemid 29232048)
9. Kocsis JH, Frances AJ,. 1987. A critical discussion of DSM-III dysthymic disorder. Am J Psychiatry 144: 1534-1542. (Pubitemid 18005547)
10. Kronfol Z, Remick DG,. 2000. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157: 683-693.
11. Maes M,. 1995. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19: 11-38.
12. Maes M,. 1997. The immune pathophysiology of major depression. In Depression Neurobiological Psychophysiological and Theraupic Advances, Honing A, van Praag H, (eds). Chester: Wiley; 197-215.
13. Mitoma M, Yoshimura R, Sugita A, Umene W, Hori H, Nakano H, et al,. 2008. Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress? Prog Neuropsychopharmacol Biol Psychiatry 32: 679-685. (Pubitemid 351312365)
14. Rihmer Z, Szadoczky E,. 1993. Dexamethasone suppression test and TSH-TSH test in subaffective dysthymia and character-spectrum disorder. J Affect Disord 28: 287-291. (Pubitemid 23240266)
15. Schlatter J, Ortuno F, Cervera-Enguix S,. 2004a. Differences in interleukin's patterns between dysthymia and major depression. Eur Psychiatry 16: 319-319.
16. Schlatter J, Ortuno F, Cervera-Enguix S,. 2004b. Monocytic patterns in patients with dysthymia versus major depression. J Affect Disord 78: 243-247. (Pubitemid 38167743)
17. Sen S, Duman R, Sanacora G,. 2008. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analysis. Biol Psychiatry 64: 527-532.
18. Shiepers OGJ, Wichers MC, Maes M,. 2008. Cytokines and major depression, and antidepressants medications: meta-analysis and implivcatio. Biol Psychiatry 64: 527-532.
19. Sluzewka A, Rybakowski J, Bosmans E, Sabieska M, Berghmans R, Maes M, et al,. 1996. Indications of immune activation in major depression. Psychiatry Res 64: 161-167. (Pubitemid 26380235)
20. Thase ME,. 2004. Mood disorders: neurobiology. In Kaplan and Sadock's Comprehensive Textbook of Psychiatry, 8th edn, Sadock VA, (ed.). Philadelphia: Lippincott Williams and Wilkins; 1318-1327.
21. Yoshimura R, Mitoma M, Sugita A, Hori H, Okamoto T, Umene W, et al. 2007. Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 31: 31-34.
22. Yoshimura R, Hori H, Ikenouchi-Sugita A, Umene-Nakano W, Ueda N, Nakamura J,. 2009. Higher plasma interleukin-6 (IL-6) is associated with SSRI- or SNRI-refractory depression. Prog Neuropsychopharmacol Biol Psychiatry 33: 722-726.